Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$6,897,354
+$2,760,553 QoQ
Shares Held
286,435
+94.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#510
of 2,822 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Sep 30, 2021CallValue
$17,204
CallShares
400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Banque Cantonale Vaudoise holds $123,482,590 across 10 Drug Manufacturers - General names. PFE ranks #8 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,866 | $26,226,738 | |
| 2 | JNJ |
Johnson & Johnson
|
90,804 | $23,061,491 | |
| 3 | ABBV |
AbbVie Inc.
|
89,306 | $22,472,961 | |
| 4 | MRK |
Merck & Co., Inc.
|
105,147 | $13,511,389 | |
| 5 | AZN |
Astrazeneca PLC
|
60,462 | $11,464,804 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
63,781 | $8,058,091 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
136,299 | $7,853,548 | |
| 8 | PFE |
Pfizer Inc
This page
|
286,435 | $6,897,354 |
All Filings in PFE
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,897,354 | 286,435 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $4,136,801 | 147,322 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $5,037,942 | 202,327 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $4,822,802 | 189,278 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,824,286 | 281,530 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $6,595,063 | 260,263 | Shares | Sole | 2025-05-08 | |
| 2024-09-30 | $11,150,117 | 385,284 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $13,026,536 | 465,566 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $13,034,479 | 469,711 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $6,916,509 | 240,240 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $11,757,703 | 354,468 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $13,452,976 | 366,766 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $13,445,435 | 329,545 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $16,790,989 | 327,693 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $12,671,757 | 289,574 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $15,604,425 | 297,624 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $17,540,296 | 338,812 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $17,914,175 | 303,373 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $17,204 | 400 | Call | Sole | 2021-10-29 | |
| 2021-09-30 | $15,220,335 | 353,879 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $15,589,243 | 398,091 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $13,334,704 | 368,057 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $15,098,283 | 410,168 | Shares | Sole | 2021-02-05 | |
| 2020-12-31 | $7,362 | 200 | Call | Sole | 2021-02-05 | |
| 2020-09-30 | $15,282,378 | 416,414 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $9,008,073 | 275,476 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $10,299,243 | 315,541 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||